Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial | 94 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial | 3 | 4 | 1 | 4 | 7 | 14 | 1 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 29 |
| China | 16 |
| Australia | 12 |
| Netherlands | 8 |
| Vietnam | 8 |
| Singapore | 5 |
| Germany | 3 |
| Argentina | 2 |
| France | 1 |
| India | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 9 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Boardman | 3 |
| Zhengzhou | 3 |
| Beijing | 2 |
| Brisbane | 2 |
| New York | 2 |
| Singapore | 2 |
| Sydney | 2 |